In vitro and mouse studies suggest that disrupting interactions between TSP-1 and CD47 could help reduce bone resorption to treat myeloma-related bone disease and osteoporosis. Further details on the research, next steps and licensing status are discussed in the article.Science-Business eXchange...
CD47; thrombospondin-1 (TSP-1; THBS1)In vitro and mouse studies suggest that blocking CD47 signaling could help boost the efficacy of radiotherapy while protecting healthy tissues. Further details on the research, next steps and licensing status are discussed in the article.Science-Business eXchange...